25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Neurones
Buy, Hold or Sell?

Let's analyze Neurones together

I guess you are interested in Neurones. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Neurones. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Neurones

I send you an email if I find something interesting about Neurones.

1. Quick Overview

1.1. Quick analysis of Neurones (30 sec.)










1.2. What can you expect buying and holding a share of Neurones? (30 sec.)

How much money do you get?

How much money do you get?
€4.12
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€14.13
Expected worth in 1 year
€8.72
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
€-1.72
Return On Investment
-3.9%

For what price can you sell your share?

Current Price per Share
€43.80
Expected price per share
€40.00 - €45.20
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Neurones (5 min.)




Live pricePrice per Share (EOD)
€43.80
Intrinsic Value Per Share
€3.28 - €26.25
Total Value Per Share
€17.42 - €40.39

2.2. Growth of Neurones (5 min.)




Is Neurones growing?

Current yearPrevious yearGrowGrow %
How rich?$455.5m$420m$35.5m7.8%

How much money is Neurones making?

Current yearPrevious yearGrowGrow %
Making money$55.1m$49.4m$5.7m10.5%
Net Profit Margin6.7%6.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Neurones (5 min.)




2.4. Comparing to competitors in the Information Technology Services industry (5 min.)




  Industry Rankings (Information Technology Services)  


Richest
#93 / 385

Most Revenue
#53 / 385

Most Profit
#42 / 385

Most Efficient
#126 / 385
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Neurones?

Welcome investor! Neurones's management wants to use your money to grow the business. In return you get a share of Neurones.

First you should know what it really means to hold a share of Neurones. And how you can make/lose money.

Speculation

The Price per Share of Neurones is €43.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Neurones.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Neurones, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €14.13. Based on the TTM, the Book Value Change Per Share is €-1.35 per quarter. Based on the YOY, the Book Value Change Per Share is €0.94 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.92 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Neurones.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps1.914.4%1.914.4%2.034.6%1.703.9%1.413.2%
Usd Book Value Change Per Share-1.51-3.4%-1.51-3.4%1.052.4%0.431.0%0.771.8%
Usd Dividend Per Share1.032.4%1.032.4%1.112.5%0.932.1%0.501.1%
Usd Total Gains Per Share-0.48-1.1%-0.48-1.1%2.174.9%1.373.1%1.272.9%
Usd Price Per Share48.86-48.86-43.83-36.85-29.74-
Price to Earnings Ratio25.56-25.56-21.55-21.24-20.72-
Price-to-Total Gains Ratio-101.95--101.95-20.23--5.84-6.69-
Price to Book Ratio3.10-3.10-2.54-2.27-2.15-
Price-to-Total Gains Ratio-101.95--101.95-20.23--5.84-6.69-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share48.91584
Number of shares20
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share1.030.93
Usd Book Value Change Per Share-1.510.43
Usd Total Gains Per Share-0.481.37
Gains per Quarter (20 shares)-9.5827.32
Gains per Year (20 shares)-38.34109.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
182-121-48753599
2165-242-8614969208
3247-362-124224104317
4330-483-162298139426
5412-604-200373173535
6495-725-238448208644
7577-846-276522243753
8660-967-314597278862
9742-1087-352671312971
10825-1208-3907463471080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%22.02.00.091.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.04.083.3%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%23.01.00.095.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Neurones compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.352-1.3520%0.943-243%0.388-448%0.691-296%
Book Value Per Share--14.13114.1310%15.483-9%14.483-2%12.246+15%
Current Ratio--2.3842.3840%2.446-3%2.553-7%2.444-2%
Debt To Asset Ratio--0.3950.3950%0.391+1%0.374+6%0.368+7%
Debt To Equity Ratio--0.7520.7520%0.728+3%0.675+11%0.650+16%
Dividend Per Share--0.9230.9230%0.997-7%0.835+11%0.447+106%
Eps--1.7121.7120%1.821-6%1.525+12%1.258+36%
Free Cash Flow Per Share--1.8741.8740%1.826+3%2.152-13%1.453+29%
Free Cash Flow To Equity Per Share--0.9360.9360%0.341+174%1.043-10%0.904+4%
Gross Profit Margin--1.0001.0000%1.0000%1.884-47%1.422-30%
Intrinsic Value_10Y_max--26.255--------
Intrinsic Value_10Y_min--3.285--------
Intrinsic Value_1Y_max--2.260--------
Intrinsic Value_1Y_min--1.182--------
Intrinsic Value_3Y_max--7.074--------
Intrinsic Value_3Y_min--2.833--------
Intrinsic Value_5Y_max--12.228--------
Intrinsic Value_5Y_min--3.685--------
Market Cap1063157400.000-19%1262931031.2501262931031.2500%953380027.250+32%841460584.380+50%666730719.930+89%
Net Profit Margin--0.0670.0670%0.066+0%0.064+5%0.059+12%
Operating Margin--0.1100.1100%0.107+3%0.103+7%0.099+11%
Operating Ratio--1.2801.2800%0.893+43%0.975+31%0.940+36%
Pb Ratio3.100+0%3.0963.0960%2.535+22%2.271+36%2.146+44%
Pe Ratio25.589+0%25.56025.5600%21.549+19%21.240+20%20.722+23%
Price Per Share43.800+0%43.75043.7500%39.250+11%33.000+33%26.633+64%
Price To Free Cash Flow Ratio23.374+0%23.34723.3470%21.490+9%15.917+47%22.974+2%
Price To Total Gains Ratio-102.0680%-101.951-101.9510%20.227-604%-5.838-94%6.686-1625%
Quick Ratio--3.3853.3850%3.338+1%3.3890%2.863+18%
Return On Assets--0.0730.0730%0.072+2%0.066+12%0.065+13%
Return On Equity--0.1390.1390%0.134+4%0.119+17%0.114+22%
Total Gains Per Share---0.429-0.4290%1.941-122%1.223-135%1.139-138%
Usd Book Value--455550537.600455550537.6000%420001676.800+8%407240896.640+12%339312430.080+34%
Usd Book Value Change Per Share---1.510-1.5100%1.053-243%0.434-448%0.772-296%
Usd Book Value Per Share--15.78115.7810%17.291-9%16.174-2%13.677+15%
Usd Dividend Per Share--1.0311.0310%1.114-7%0.932+11%0.500+106%
Usd Eps--1.9121.9120%2.034-6%1.704+12%1.405+36%
Usd Free Cash Flow--60411062.40060411062.4000%49545715.200+22%60285980.800+0%40358695.040+50%
Usd Free Cash Flow Per Share--2.0932.0930%2.040+3%2.404-13%1.623+29%
Usd Free Cash Flow To Equity Per Share--1.0461.0460%0.381+174%1.165-10%1.010+4%
Usd Market Cap1187334184.320-19%1410441375.7001410441375.7000%1064734814.433+32%939743180.636+50%744604868.018+89%
Usd Price Per Share48.916+0%48.86048.8600%43.834+11%36.854+33%29.744+64%
Usd Profit--55181088.00055181088.0000%49410582.400+12%43125455.360+28%35001293.760+58%
Usd Revenue--827772160.000827772160.0000%743095267.200+11%674775250.560+23%580446525.440+43%
Usd Total Gains Per Share---0.479-0.4790%2.167-122%1.366-135%1.272-138%
 EOD+1 -7MRQTTM+0 -0YOY+16 -195Y+15 -2110Y+22 -14

3.3 Fundamental Score

Let's check the fundamental score of Neurones based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1525.589
Price to Book Ratio (EOD)Between0-13.100
Net Profit Margin (MRQ)Greater than00.067
Operating Margin (MRQ)Greater than00.110
Quick Ratio (MRQ)Greater than13.385
Current Ratio (MRQ)Greater than12.384
Debt to Asset Ratio (MRQ)Less than10.395
Debt to Equity Ratio (MRQ)Less than10.752
Return on Equity (MRQ)Greater than0.150.139
Return on Assets (MRQ)Greater than0.050.073
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Neurones based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.007
Ma 20Greater thanMa 5042.508
Ma 50Greater thanMa 10042.530
Ma 100Greater thanMa 20043.316
OpenGreater thanClose43.400
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Neurones

Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, manages public and private cloud services, IT operations, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP, digital, WEB, mobility, UX/UI, enterprise content and document management, business process management, robotic process automation, dematerialization, IT consulting for finance, big data, and DevOps, IT training and change management, and Innovation connected devices (IOT). In addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, DevOps, CI/CD, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, UX/UI, and digital marketing, as well as internal process digitization, ECM/BPM, RPA, dematerialization, AI, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. The company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. Neurones S.A. was founded in 1984 and is based in Nanterre, France.

Fundamental data was last updated by Penke on 2024-09-10 07:22:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Neurones earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Neurones to the Information Technology Services industry mean.
  • A Net Profit Margin of 6.7% means that €0.07 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Neurones:

  • The MRQ is 6.7%. The company is making a profit. +1
  • The TTM is 6.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.7%TTM6.7%0.0%
TTM6.7%YOY6.6%+0.0%
TTM6.7%5Y6.4%+0.3%
5Y6.4%10Y5.9%+0.4%
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7%4.1%+2.6%
TTM6.7%3.7%+3.0%
YOY6.6%3.4%+3.2%
5Y6.4%3.4%+3.0%
10Y5.9%3.4%+2.5%
4.3.1.2. Return on Assets

Shows how efficient Neurones is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neurones to the Information Technology Services industry mean.
  • 7.3% Return on Assets means that Neurones generated €0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Neurones:

  • The MRQ is 7.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.3%TTM7.3%0.0%
TTM7.3%YOY7.2%+0.2%
TTM7.3%5Y6.6%+0.8%
5Y6.6%10Y6.5%+0.1%
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ7.3%1.4%+5.9%
TTM7.3%1.3%+6.0%
YOY7.2%1.3%+5.9%
5Y6.6%1.2%+5.4%
10Y6.5%1.3%+5.2%
4.3.1.3. Return on Equity

Shows how efficient Neurones is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neurones to the Information Technology Services industry mean.
  • 13.9% Return on Equity means Neurones generated €0.14 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Neurones:

  • The MRQ is 13.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.9%TTM13.9%0.0%
TTM13.9%YOY13.4%+0.6%
TTM13.9%5Y11.9%+2.1%
5Y11.9%10Y11.4%+0.5%
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ13.9%3.0%+10.9%
TTM13.9%2.8%+11.1%
YOY13.4%2.9%+10.5%
5Y11.9%2.8%+9.1%
10Y11.4%2.9%+8.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Neurones.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Neurones is operating .

  • Measures how much profit Neurones makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neurones to the Information Technology Services industry mean.
  • An Operating Margin of 11.0% means the company generated €0.11  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Neurones:

  • The MRQ is 11.0%. The company is operating less efficient.
  • The TTM is 11.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.0%TTM11.0%0.0%
TTM11.0%YOY10.7%+0.3%
TTM11.0%5Y10.3%+0.7%
5Y10.3%10Y9.9%+0.4%
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ11.0%7.2%+3.8%
TTM11.0%5.7%+5.3%
YOY10.7%5.0%+5.7%
5Y10.3%4.6%+5.7%
10Y9.9%4.5%+5.4%
4.3.2.2. Operating Ratio

Measures how efficient Neurones is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Information Technology Services industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are €1.28 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Neurones:

  • The MRQ is 1.280. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.280. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.280TTM1.2800.000
TTM1.280YOY0.893+0.387
TTM1.2805Y0.975+0.305
5Y0.97510Y0.940+0.035
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2801.323-0.043
TTM1.2801.249+0.031
YOY0.8931.032-0.139
5Y0.9751.102-0.127
10Y0.9401.063-0.123
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Neurones.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Neurones is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Information Technology Services industry mean).
  • A Current Ratio of 2.38 means the company has €2.38 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Neurones:

  • The MRQ is 2.384. The company is able to pay all its short-term debts. +1
  • The TTM is 2.384. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.384TTM2.3840.000
TTM2.384YOY2.446-0.062
TTM2.3845Y2.553-0.169
5Y2.55310Y2.444+0.109
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3841.466+0.918
TTM2.3841.464+0.920
YOY2.4461.537+0.909
5Y2.5531.643+0.910
10Y2.4441.637+0.807
4.4.3.2. Quick Ratio

Measures if Neurones is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neurones to the Information Technology Services industry mean.
  • A Quick Ratio of 3.38 means the company can pay off €3.38 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Neurones:

  • The MRQ is 3.385. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.385. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.385TTM3.3850.000
TTM3.385YOY3.338+0.047
TTM3.3855Y3.389-0.004
5Y3.38910Y2.863+0.526
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3850.898+2.487
TTM3.3850.923+2.462
YOY3.3381.133+2.205
5Y3.3891.201+2.188
10Y2.8631.267+1.596
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Neurones.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Neurones assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neurones to Information Technology Services industry mean.
  • A Debt to Asset Ratio of 0.40 means that Neurones assets are financed with 39.5% credit (debt) and the remaining percentage (100% - 39.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Neurones:

  • The MRQ is 0.395. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.395. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.395TTM0.3950.000
TTM0.395YOY0.391+0.004
TTM0.3955Y0.374+0.021
5Y0.37410Y0.368+0.006
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3950.499-0.104
TTM0.3950.492-0.097
YOY0.3910.495-0.104
5Y0.3740.499-0.125
10Y0.3680.489-0.121
4.5.4.2. Debt to Equity Ratio

Measures if Neurones is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neurones to the Information Technology Services industry mean.
  • A Debt to Equity ratio of 75.2% means that company has €0.75 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Neurones:

  • The MRQ is 0.752. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.752. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.752TTM0.7520.000
TTM0.752YOY0.728+0.023
TTM0.7525Y0.675+0.076
5Y0.67510Y0.650+0.026
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7520.932-0.180
TTM0.7520.952-0.200
YOY0.7280.953-0.225
5Y0.6751.002-0.327
10Y0.6501.049-0.399
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Neurones generates.

  • Above 15 is considered overpriced but always compare Neurones to the Information Technology Services industry mean.
  • A PE ratio of 25.56 means the investor is paying €25.56 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Neurones:

  • The EOD is 25.589. Based on the earnings, the company is overpriced. -1
  • The MRQ is 25.560. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.560. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD25.589MRQ25.560+0.029
MRQ25.560TTM25.5600.000
TTM25.560YOY21.549+4.012
TTM25.5605Y21.240+4.320
5Y21.24010Y20.722+0.518
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
EOD25.58916.858+8.731
MRQ25.56015.992+9.568
TTM25.56015.810+9.750
YOY21.54914.262+7.287
5Y21.24018.560+2.680
10Y20.72220.691+0.031
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Neurones:

  • The EOD is 23.374. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 23.347. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 23.347. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD23.374MRQ23.347+0.027
MRQ23.347TTM23.3470.000
TTM23.347YOY21.490+1.857
TTM23.3475Y15.917+7.431
5Y15.91710Y22.974-7.057
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
EOD23.3746.566+16.808
MRQ23.3475.973+17.374
TTM23.3474.406+18.941
YOY21.4904.080+17.410
5Y15.9175.321+10.596
10Y22.9744.938+18.036
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Neurones is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Information Technology Services industry mean).
  • A PB ratio of 3.10 means the investor is paying €3.10 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Neurones:

  • The EOD is 3.100. Based on the equity, the company is fair priced.
  • The MRQ is 3.096. Based on the equity, the company is fair priced.
  • The TTM is 3.096. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.100MRQ3.096+0.004
MRQ3.096TTM3.0960.000
TTM3.096YOY2.535+0.561
TTM3.0965Y2.271+0.825
5Y2.27110Y2.146+0.125
Compared to industry (Information Technology Services)
PeriodCompanyIndustry (mean)+/- 
EOD3.1002.411+0.689
MRQ3.0962.294+0.802
TTM3.0962.456+0.640
YOY2.5352.478+0.057
5Y2.2712.966-0.695
10Y2.1463.297-1.151
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets674,251
Total Liabilities266,344
Total Stockholder Equity354,389
 As reported
Total Liabilities 266,344
Total Stockholder Equity+ 354,389
Total Assets = 674,251

Assets

Total Assets674,251
Total Current Assets545,813
Long-term Assets128,438
Total Current Assets
Cash And Cash Equivalents 297,758
Short-term Investments 242,625
Net Receivables 234,473
Inventory 709
Total Current Assets  (as reported)545,813
Total Current Assets  (calculated)775,565
+/- 229,752
Long-term Assets
Property Plant Equipment 58,725
Goodwill 51,666
Intangible Assets 1,197
Long-term Assets  (as reported)128,438
Long-term Assets  (calculated)111,588
+/- 16,850

Liabilities & Shareholders' Equity

Total Current Liabilities228,923
Long-term Liabilities37,421
Total Stockholder Equity354,389
Total Current Liabilities
Short-term Debt 13,056
Short Long Term Debt 5,835
Accounts payable 44,041
Other Current Liabilities 147,647
Total Current Liabilities  (as reported)228,923
Total Current Liabilities  (calculated)210,579
+/- 18,344
Long-term Liabilities
Long term Debt 1,510
Capital Lease Obligations 36,637
Long-term Liabilities  (as reported)37,421
Long-term Liabilities  (calculated)38,147
+/- 726
Total Stockholder Equity
Common Stock9,711
Retained Earnings 311,537
Accumulated Other Comprehensive Income 2,206
Other Stockholders Equity 30,935
Total Stockholder Equity (as reported)354,389
Total Stockholder Equity (calculated)354,389
+/-0
Other
Capital Stock9,711
Cash and Short Term Investments 297,758
Common Stock Shares Outstanding 28,867
Current Deferred Revenue24,179
Liabilities and Stockholders Equity 674,251
Net Debt -253,776
Net Invested Capital 361,734
Net Working Capital 316,890
Property Plant and Equipment Gross 154,725
Short Long Term Debt Total 43,982



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
62,372
74,492
78,872
82,278
93,069
100,847
118,258
135,477
165,637
169,048
189,963
225,466
249,997
278,716
304,168
351,196
385,631
411,694
449,056
510,138
549,851
567,823
617,241
674,251
674,251617,241567,823549,851510,138449,056411,694385,631351,196304,168278,716249,997225,466189,963169,048165,637135,477118,258100,84793,06982,27878,87274,49262,372
   > Total Current Assets 
0
0
63,184
67,044
76,896
84,159
94,607
109,768
122,010
125,637
145,057
179,192
201,958
229,083
253,519
284,013
318,630
346,424
383,379
412,813
449,070
464,129
506,571
545,813
545,813506,571464,129449,070412,813383,379346,424318,630284,013253,519229,083201,958179,192145,057125,637122,010109,76894,60784,15976,89667,04463,18400
       Cash And Cash Equivalents 
10,990
3,176
4,520
5,970
46,634
50,488
48,415
57,022
54,777
60,441
68,609
75,493
87,858
101,055
123,153
131,373
141,405
154,606
174,949
98,225
143,488
95,572
76,711
297,758
297,75876,71195,572143,48898,225174,949154,606141,405131,373123,153101,05587,85875,49368,60960,44154,77757,02248,41550,48846,6345,9704,5203,17610,990
       Short-term Investments 
16,924
32,473
31,471
35,278
37,648
0
0
0
0
0
0
0
-10
0
0
0
11,293
82,589
75,295
120,380
123,115
169,602
195,347
242,625
242,625195,347169,602123,115120,38075,29582,58911,293000-10000000037,64835,27831,47132,47316,924
       Net Receivables 
21,468
25,671
24,018
22,270
29,187
32,969
44,913
52,498
65,306
64,945
76,313
100,618
110,618
108,979
107,386
124,562
145,193
157,277
170,052
185,108
174,357
188,596
223,948
234,473
234,473223,948188,596174,357185,108170,052157,277145,193124,562107,386108,979110,618100,61876,31364,94565,30652,49844,91332,96929,18722,27024,01825,67121,468
       Inventory 
345
319
284
139
266
193
120
247
270
252
134
379
200
206
172
409
245
891
278
614
1,307
1,529
989
709
7099891,5291,307614278891245409172206200379134252270247120193266139284319345
   > Long-term Assets 
0
0
15,688
15,234
16,173
16,688
23,651
25,709
43,627
43,411
44,906
46,274
48,039
45,628
46,415
63,093
62,052
60,332
59,875
97,325
100,781
103,694
110,670
128,438
128,438110,670103,694100,78197,32559,87560,33262,05263,09346,41545,62848,03946,27444,90643,41143,62725,70923,65116,68816,17315,23415,68800
       Property Plant Equipment 
1,380
1,564
1,525
1,573
1,477
1,550
2,132
2,963
3,652
3,634
4,163
5,649
6,279
7,668
8,282
14,594
14,495
16,231
16,211
47,148
46,644
46,103
49,798
58,725
58,72549,79846,10346,64447,14816,21116,23114,49514,5948,2827,6686,2795,6494,1633,6343,6522,9632,1321,5501,4771,5731,5251,5641,380
       Goodwill 
0
0
11,765
11,112
0
13,572
18,493
20,669
34,515
34,515
34,545
36,129
36,460
36,173
35,892
37,135
42,404
40,024
39,904
39,904
42,120
44,413
45,024
51,666
51,66645,02444,41342,12039,90439,90440,02442,40437,13535,89236,17336,46036,12934,54534,51534,51520,66918,49313,572011,11211,76500
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,260
1,557
8,583
3,010
2,711
3,062
0
0
0
0
0
000003,0622,7113,0108,5831,5571,2600000000000000
       Intangible Assets 
10,256
10,053
1,719
1,743
13,645
14,045
18,883
21,198
35,181
34,724
34,815
36,626
288
527
684
2,781
2,143
1,366
698
40,334
43,630
45,856
46,074
1,197
1,19746,07445,85643,63040,3346981,3662,1432,78168452728836,62634,81534,72435,18121,19818,88314,04513,6451,7431,71910,05310,256
       Other Assets 
0
0
0
0
0
470
1,880
604
1,126
1,100
1,496
1,929
2,403
4,005
4,234
4,090
4,949
4,938
5,802
0
7,260
0
0
0
0007,26005,8024,9384,9494,0904,2344,0052,4031,9291,4961,1001,1266041,88047000000
> Total Liabilities 
19,741
26,524
24,758
23,318
28,367
30,195
41,745
49,587
68,725
60,772
68,636
86,339
94,579
103,507
107,293
135,448
147,176
143,641
153,180
182,816
190,826
214,904
241,165
266,344
266,344241,165214,904190,826182,816153,180143,641147,176135,448107,293103,50794,57986,33968,63660,77268,72549,58741,74530,19528,36723,31824,75826,52419,741
   > Total Current Liabilities 
18,128
25,272
24,589
22,871
28,292
30,131
39,370
47,544
66,940
60,096
68,192
86,030
94,138
102,926
106,571
132,658
145,245
142,126
151,736
156,429
161,432
184,560
207,101
228,923
228,923207,101184,560161,432156,429151,736142,126145,245132,658106,571102,92694,13886,03068,19260,09666,94047,54439,37030,13128,29222,87124,58925,27218,128
       Short-term Debt 
0
0
0
0
29
652
628
0
0
0
0
446
102
174
362
1,663
1,825
1,144
373
7,064
6,945
7,498
8,164
13,056
13,0568,1647,4986,9457,0643731,1441,8251,6633621741024460000628652290000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
174
362
3,474
1,825
1,144
373
164
265
205
152
5,835
5,8351522052651643731,1441,8253,4743621740000000000000
       Accounts payable 
4,752
5,575
5,052
5,626
6,520
6,771
8,809
44,076
60,534
58,660
65,476
83,068
16,286
19,045
16,725
29,769
26,202
29,384
31,250
31,041
32,657
37,727
42,927
44,041
44,04142,92737,72732,65731,04131,25029,38426,20229,76916,72519,04516,28683,06865,47658,66060,53444,0768,8096,7716,5205,6265,0525,5754,752
       Other Current Liabilities 
11,582
17,791
24,589
22,871
21,743
22,708
29,933
3,468
6,406
1,436
2,716
2,516
77,852
83,881
89,846
102,889
119,043
100,934
104,838
103,593
106,480
119,640
134,576
147,647
147,647134,576119,640106,480103,593104,838100,934119,043102,88989,84683,88177,8522,5162,7161,4366,4063,46829,93322,70821,74322,87124,58917,79111,582
   > Long-term Liabilities 
0
0
169
447
75
64
2,375
2,043
1,785
676
444
309
441
581
722
1,893
862
240
2
26,387
29,394
30,344
34,064
37,421
37,42134,06430,34429,39426,38722408621,8937225814413094446761,7852,0432,375647544716900
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
862
240
2
24,569
27,234
27,825
27,936
0
027,93627,82527,23424,56922408620000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-29
-652
-628
0
0
0
0
-446
-102
-174
-362
-1,663
-1,825
-1,144
-373
24,401
26,598
27,415
27,674
23,581
23,58127,67427,41526,59824,401-373-1,144-1,825-1,663-362-174-102-4460000-628-652-290000
> Total Stockholder Equity
42,031
47,267
51,672
55,836
62,945
68,623
74,041
79,380
91,291
101,982
114,216
129,406
144,220
161,780
180,501
198,422
217,040
242,973
266,831
297,173
322,626
311,559
331,078
354,389
354,389331,078311,559322,626297,173266,831242,973217,040198,422180,501161,780144,220129,406114,216101,98291,29179,38074,04168,62362,94555,83651,67247,26742,031
   Common Stock
9,108
9,108
9,108
9,108
9,139
9,266
9,299
9,353
9,191
9,390
9,424
9,449
9,504
9,585
9,593
9,693
9,698
9,698
9,714
9,714
9,687
9,691
9,691
9,711
9,7119,6919,6919,6879,7149,7149,6989,6989,6939,5939,5859,5049,4499,4249,3909,1919,3539,2999,2669,1399,1089,1089,1089,108
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
-7,043
-8,711
-11,867
-14,309
102,779
119,419
40,723
693
254
-464
-680
-403
79
1,485
2,206
2,2061,48579-403-680-46425469340,723119,419102,779-14,309-11,867-8,711-7,043000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,381
31,424
31,424
31,407
31,407
31,407
31,403
31,403
0
031,40331,40331,40731,40731,40731,42431,42431,381000000000000000
   Treasury Stock000000-252-252-351-177-213-2460-9900000000000
   Other Stockholders Equity 
0
0
42,564
46,728
48,383
53,430
58,601
70,027
28,189
92,592
30,734
30,986
-24,353
30,846
30,984
126,648
181,450
205,711
231,158
31,293
31,221
31,142
31,218
30,935
30,93531,21831,14231,22131,293231,158205,711181,450126,64830,98430,846-24,35330,98630,73492,59228,18970,02758,60153,43048,38346,72842,56400



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue741,200
Cost of Revenue-283,665
Gross Profit457,535457,535
 
Operating Income (+$)
Gross Profit457,535
Operating Expense-665,300
Operating Income75,900-207,765
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense665,3000
 
Net Interest Income (+$)
Interest Income5,917
Interest Expense-1,434
Other Finance Cost-0
Net Interest Income4,483
 
Pretax Income (+$)
Operating Income75,900
Net Interest Income4,483
Other Non-Operating Income Expenses-
Income Before Tax (EBT)80,765151,800
EBIT - interestExpense = 80,032
71,610
50,844
Interest Expense1,434
Earnings Before Interest and Taxes (EBIT)81,46682,199
Earnings Before Interest and Taxes (EBITDA)97,366
 
After tax Income (+$)
Income Before Tax80,765
Tax Provision-22,183
Net Income From Continuing Ops58,58258,582
Net Income49,410
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses665,300
Total Other Income/Expenses Net-75,900-4,483
 

Technical Analysis of Neurones
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Neurones. The general trend of Neurones is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Neurones's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Neurones.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 44.85 < 44.95 < 45.20.

The bearish price targets are: 41.10 > 41.10 > 40.00.

Tweet this
Neurones Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Neurones. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Neurones Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Neurones. The current macd is 0.17178994.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neurones price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Neurones. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Neurones price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Neurones Daily Moving Average Convergence/Divergence (MACD) ChartNeurones Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Neurones. The current adx is 16.57.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Neurones shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Neurones Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Neurones. The current sar is 41.88.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Neurones Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Neurones. The current rsi is 60.01. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Neurones Daily Relative Strength Index (RSI) ChartNeurones Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Neurones. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neurones price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Neurones Daily Stochastic Oscillator ChartNeurones Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Neurones. The current cci is 133.02.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Neurones Daily Commodity Channel Index (CCI) ChartNeurones Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Neurones. The current cmo is 32.56.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Neurones Daily Chande Momentum Oscillator (CMO) ChartNeurones Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Neurones. The current willr is -18.18181818.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Neurones Daily Williams %R ChartNeurones Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Neurones.

Neurones Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Neurones. The current atr is 0.72206419.

Neurones Daily Average True Range (ATR) ChartNeurones Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Neurones. The current obv is 193,549.

Neurones Daily On-Balance Volume (OBV) ChartNeurones Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Neurones. The current mfi is 51.67.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Neurones Daily Money Flow Index (MFI) ChartNeurones Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Neurones.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-06-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Neurones Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Neurones based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.007
Ma 20Greater thanMa 5042.508
Ma 50Greater thanMa 10042.530
Ma 100Greater thanMa 20043.316
OpenGreater thanClose43.400
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Neurones with someone you think should read this too:
  • Are you bullish or bearish on Neurones? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Neurones? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Neurones

I send you an email if I find something interesting about Neurones.


Comments

How you think about this?

Leave a comment

Stay informed about Neurones.

Receive notifications about Neurones in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.